Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00255970 · ClinicalTrials.gov registry record · Phase 2
Regenafil Versus Demineralized Freeze Dried Bone Allograft (DFDBA) for Periodontal Defects
A Phase 2 study, sponsored by RTI Surgical.
- Completed
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
NCT00255970 is a Phase 2 study that has completed, run by RTI Surgical. The registered enrollment target is 40 participants.
The verdict
NCT00255970, a Phase 2 study, has completed, sponsored by RTI Surgical.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this research study was to determine whether treatment with the bone grafting material Regenafil was as effective as the standard treatment using demineralized freeze dried bone allograft (DFDBA). Regenafil is demineralized freeze dried bone in a special gel form.
Interventions
- OTHER DFDBA
- DEVICE Regenafil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-01 |
| Est. Completion | 2007-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00255970
The ClinicalTrials.gov registry entry for NCT00255970 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RTI Surgical, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DFDBA is the first listed.
NCT00255970 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00255970 about?
NCT00255970 is a clinical study titled "Regenafil Versus Demineralized Freeze Dried Bone Allograft (DFDBA) for Periodontal Defects". The purpose of this research study was to determine whether treatment with the bone grafting material Regenafil was as effective as the standard treatment using demineralized freeze dried bone allograft (DFDBA). Regenafil is demineralized freeze dried bone in a special gel form.
What is the current status of trial NCT00255970?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2006-01. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00255970?
The interventions under investigation include: DFDBA (OTHER), Regenafil (DEVICE).
Who is sponsoring clinical trial NCT00255970?
This trial is sponsored by RTI Surgical, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.